Evidence map›Paper›PMID 27833538›Full record

ArticleFrontiers in behavioral neuroscience2016

Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.

Nicole El Massioui, Charlotte Lamirault, Sara Yagüe, Najia Adjeroud, Daniel Garces, Alexis Maillard, Lucille Tallot, Libo Yu-Taeger, Olaf Riess, Philippe Allain and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Nicole El MassiouiInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Charlotte LamiraultInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Sara YagüeInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Najia AdjeroudInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris SaclayOrsay, France; Neuropsychological Unit, Department of Neurology, CHU AngersFrance.
Daniel GarcesThe Graduate Center, City University of New York (CUNY) New York, NY, USA.
Alexis MaillardInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Lucille TallotInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Libo Yu-TaegerInstitute of Medical Genetics and Applied Genomics, University of TuebingenTuebingen, Germany; Center for Rare Diseases, University of TuebingenTuebingen, Germany.
Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of TuebingenTuebingen, Germany; Center for Rare Diseases, University of TuebingenTuebingen, Germany.
Philippe AllainNeuropsychological Unit, Department of Neurology, CHU Angers France.
Huu Phuc NguyenInstitute of Medical Genetics and Applied Genomics, University of TuebingenTuebingen, Germany; Center for Rare Diseases, University of TuebingenTuebingen, Germany.
Stephan von HörstenExperimental Therapy, Franz Penzoldt Center, Friedrich-Alexander University, Erlangen-Nürnberg Germany.
Valérie DoyèreInstitut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197, Centre National de la Recherche Scientifique (CNRS) Université Paris Sud, Université Paris Saclay Orsay, France.
Centre National de la Recherche Scientifique · FRUniversity of Tübingen · DEUniversité Paris-Saclay · FRUniversité Paris-Sud · FRCentre Hospitalier Universitaire d'Angers · FRCity University of New York · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive deficits associated with Huntington disease (HD) are generally dominated by executive function disorders often associated with disinhibition and impulsivity/compulsivity. Few studies have directly examined symptoms and consequences of behavioral disinhibition in HD and its relation with decision-making. To assess the different forms of impulsivity in a transgenic model of HD (tgHD rats), two tasks assessing cognitive/choice impulsivity were used: risky decision-making with a rat gambling task (RGT) and intertemporal choices with a delay discounting task (DD). To assess waiting or action impulsivity the differential reinforcement of low rate of responding task (DRL) was used. In parallel, the volume as well as cellular activity of the amygdala was analyzed. In contrast to WT rats, 15 months old tgHD rats exhibited a poor efficiency in the RGT task with difficulties to choose advantageous options, a steep DD curve as delays increased in the DD task and a high rate of premature and bursts responses in the DRL task. tgHD rats also demonstrated a concomitant and correlated presence of both action and cognitive/choice impulsivity in contrast to wild type (WT) animals. Moreover, a reduced volume associated with an increased basal cellular activity of the central nucleus of amygdala indicated a dysfunctional amygdala in tgHD rats, which could underlie inhibitory dyscontrol. In conclusion, tgHD rats are a good model for impulsivity disorder that could be used more widely to identify potential pharmacotherapies to treat these invasive symptoms in HD.

Indexed as

decision-makingdelay discountingDRLgambling taskHuntington diseaseimpulsivity

Identifiers

PMID27833538
PMCPMC5080295
OpenAlexW2534470141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.